# Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults

> **NCT03821623** · PHASE2 · RECRUITING · sponsor: **Douglas Seals** · enrollment: 118 (estimated)

## Conditions studied

- Hypertension
- Aging

## Interventions

- **DRUG:** Nicotinamide riboside
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03821623
- **Lead sponsor:** Douglas Seals
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-05-10
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 118 (ESTIMATED)
- **Last updated:** 2025-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03821623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03821623, "Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03821623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*